Anticancer therapy with HDAC inhibitors: mechanism-based combination strategies and future perspectives
R Jenke, N Reßing, FK Hansen, A Aigner, T Büch - Cancers, 2021 - mdpi.com
Simple Summary Beyond mutations, epigenetic changes have been described as drivers for
cancer as well. While leaving the overall DNA structure intact, they can be responsible for …
cancer as well. While leaving the overall DNA structure intact, they can be responsible for …
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
M You, Z Xie, N Zhang, Y Zhang, D Xiao, S Liu… - … and Targeted Therapy, 2023 - nature.com
A wide spectrum of metabolites (mainly, the three major nutrients and their derivatives) can
be sensed by specific sensors, then trigger a series of signal transduction pathways and …
be sensed by specific sensors, then trigger a series of signal transduction pathways and …
Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
B Pasculli, R Barbano, P Parrella - Seminars in cancer biology, 2018 - Elsevier
In the last years, mortality from breast cancer has declined in western countries as a
consequence of a more widespread screening resulting in earlier detection, as well as an …
consequence of a more widespread screening resulting in earlier detection, as well as an …
Epigenetic therapy of cancer with histone deacetylase inhibitors
KC Lakshmaiah, LA Jacob, S Aparna… - Journal of cancer …, 2014 - journals.lww.com
Epigenetics is the study of heritable alterations in gene expression that are not accompanied
by the corresponding change in DNA sequence. Three interlinked epigenetic processes …
by the corresponding change in DNA sequence. Three interlinked epigenetic processes …
Epigenetic treatment of solid tumours: a review of clinical trials
C Nervi, E De Marinis, G Codacci-Pisanelli - Clinical epigenetics, 2015 - Springer
Epigenetic treatment has been approved by regulatory agencies for haematological
malignancies. The success observed in cutaneous lymphomas represents a proof of …
malignancies. The success observed in cutaneous lymphomas represents a proof of …
Vorinostat (SAHA) and breast cancer: an overview
A Wawruszak, L Borkiewicz, E Okon, W Kukula-Koch… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer (BC) is the most frequent malignancy diagnosed in 2020
worldwide. Despite significant advances in BC therapy, its pathogenesis is still not fully …
worldwide. Despite significant advances in BC therapy, its pathogenesis is still not fully …
Harnessing epigenetics for breast cancer therapy: The role of DNA methylation, histone modifications, and MicroRNA
J Szczepanek, M Skorupa, J Jarkiewicz-Tretyn… - International Journal of …, 2023 - mdpi.com
Breast cancer exhibits various epigenetic abnormalities that regulate gene expression and
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …
Drug repositioning with adaptive graph convolutional networks
Motivation Drug repositioning is an effective strategy to identify new indications for existing
drugs, providing the quickest possible transition from bench to bedside. With the rapid …
drugs, providing the quickest possible transition from bench to bedside. With the rapid …
Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents
Highlights•Breast cancer is the most frequently diagnosed cancer in women.•Aberrant
expression of HATs and HDACs has been reported in breast cancer.•Epigenetic therapy is …
expression of HATs and HDACs has been reported in breast cancer.•Epigenetic therapy is …